[Pharmacotherapy of non-associated with Helicobacter pylori ulcer].

Abstract

Examination and pharmacotherapy were performed in 77 patients with ulcer disease (48 patients with duodenal ulcer, 29 patients had gastric ulcer). The disease was not associated with Helicobacter pylori. Ulcer disease free of Helicobacter pylori was treated with famotidine within 5 days since the recurrence onset (in acute phase of ulcer defect) followed by intake of phosphalugel (in duodenal ulcer) or de-nol (in gastric ulcer). Such treatment appeared more effective than ranitidine therapy as it consolidates stable remission and produced minimal side effects.

• Authors: V B Grinevich, Iu P Uspenskiĭ, G Zh Shabanova, O A Sablin, N N Shcherbina
• Journal: Klinicheskaia meditsina (Klin Med (Mosk)) Vol. 80 Issue 10 Pg. 44-6 ( 2002) ISSN: 0023-2149 [Print] Russia (Federation)
• Vernacular Title: Farmakoterapiia iazvennoĭ bolezni, ne assotsiirovannoĭ s Helocobacter pylori.
• PMID: 12471838 (Publication Type: Journal Article)

Chemical References

• Antacids
• Anti-Ulcer Agents
• Famotidine

Topics

• Adult
• Antacids (therapeutic use)
• Anti-Ulcer Agents (therapeutic use)
• Duodenal Ulcer (drug therapy)
• Famotidine (therapeutic use)
• Female
• Helicobacter pylori
• Humans
• Male
• Stomach Ulcer (drug therapy)
• Treatment Outcome